This study aimed to evaluate the effect of COVID-19 infection on obstetric complicationsand maternal outcomes.
During the SARS-CoV-2 pandemic, pregnant women were reported to have a higher
susceptibility to COVID-19 infection. Pregnant women who tested positive for SARS-CoV-2
are at higher risk of a severe form of COVID-19, associated with higher rates of
intensive care unit (ICU) admission and increased needs for respiratory support, compared
to the age-matched non-pregnant population.
Women infected during pregnancy also have an increased risk of adverse pregnancy outcomes
including preterm-birth, with a significant proportion secondary to iatrogenic preterm
birth due to maternal illness. Infection with SARS-CoV-2 during pregnancy has also been
reported to be associated with a higher risk of stillbirth directly or indirectly caused
by the virus.
Infected pregnant patients tended to present asymptomatically with pre-Delta and Omicron
variants, and symptomatically with Delta variant. A previous systematic review suggested
that people who are pregnant did not have an increased risk of SARS-CoV-2 infection or
symptomatic COVID-19, but they were at risk of severe COVID-19 compared with those who
were not pregnant.
Other: Data collection
Data collected included maternal demographics, medication during pregnancy, the
gestational week when COVID-19 was diagnosed, antenatal diseases occurring after COVID-19
detection during pregnancy, intrauterine growth retardation (IUGR), small for gestational
age (SGA), fetal distress, intrauterine fetal demise (IUFD), intrapartum complications,
gestational age (GA) at delivery, mode of delivery, postpartum hemorrhage (PPH),
admission to the maternal ICU, birth weight, admission to the NICU, and the indication
for NICU hospitalization Pregnancy outcomes included mode of delivery, gestational age at
delivery, pre-eclampsia, and postpartum hemorrhage (defined as an estimated blood loss of
1,000 mL or greater).
Inclusion Criteria:
- Age from 18 to 40 years.
- Pregnant women with COVID-19 infection diagnosed either by PCR or rapid test.
Exclusion Criteria:
• Patients vaccinated for COVID-19 before or during the current pregnancy.
Tanta University
Tanta 347497, El-Gharbia, Egypt
Not Provided